Clinical Trial

ICOPE INTENSE-K Pilot Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
ICOPE could constitute the reference model of care for healthy aging. More specifically, our hypothesis is that the intervention implemented in ICOPE may directly or indirectly prevent immuno-senescence, the loss of mobility and the cognitive decline. In future Geroscience clinical trials, ICOPE-Intense could become a benchmark to reduce the rate of aging with a strong non-pharmacological intervention and state a reference intervention to compare with new gerotherapeutic drugs.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-24.
Status change: Not Yet Recruiting → Recruiting 2025-07-22
Trial Details
NCT Number NCT07048860
Lead Sponsor University Hospital, Toulouse
Conditions Ageing
Enrollment 40 participants
Start Date 2025-07-09
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-23